Cited by 9Oral and gingival health researchOral Health Pathology and TreatmentOral microbiology and periodontitis research

Immunoexpression of interleukin-6 in drug-induced gingival overgrowth patients

Open access
Ganesh, PR·2016·Contemporary Clinical Dentistry

Abstract

BACKGROUND: To analyze the role of proinflammatory cytokines in drug-induced gingival enlargement in Indian population. AIM: To evaluate for the presence of interleukin-6 (IL-6) in drug-induced gingival enlargement and to compare it with healthy control in the absence of enlargement. MATERIALS AND METHODS: Thirty-five patients selected for the study and divided into control group (10) and study group (25) consisting of phenytoin (10); cyclosporin (10) and nifedipine (5) induced gingival enlargement. Gingival overgrowth index of Seymour was used to assess overgrowth and allot groups. Under LA, incisional biopsy done, tissue sample fixed in 10% formalin and immunohistochemically evaluated for the presence of IL-6 using LAB-SA method, Labeled- Streptavidin-Biotin Method (LAB-SA kit from Zymed- 2(nd) generation LAB-SA detection system, Zymed Laboratories, CA). The results of immunohistochemistry were statistically analyzed using Kruskaal-Wallis and Mann-Whitney test. RESULTS: The data obtained from immunohistochemistry assessment shows that drug-induced gingival overgrowth (DIGO) samples express more IL-6 than control group and cyclosporin expresses more IL-6 followed by phenytoin and nifedipine. CONCLUSION: Increased IL-6 expression was noticed in all three DIGO groups in comparison with control group. Among the study group, cyclosporin expressed maximum IL-6 expression followed by phenytoin and nifedipine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/0976-237x.183048

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Phenytoin decreases MMP-1 by increasing the expression of TIMP-1.

    “The result is that phenytoin decreases the MMP-1 by increasing the expression of TIMP-1.”

    From An Update on the Mechanisms of Phenytoin Induced Gingival Overgrowth (2019) · cites this paper as [49]

    The References section names a study reporting that phenytoin suppresses expression of both MMP-1 and TIMP-1, contrary to the claimed increase in TIMP-1. The Discussion attributes increased TIMP production to IL-6, not directly to phenytoin, and says it has no effect on MMP secretion. No page numbers are available in our copy. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • As a result, collagen accumulates in ECM and causes gingival overgrowth.

    “As a result of this, collagen accumulates in ECM and causes gingival overgrowth [44, 49, 50].”

    From An Update on the Mechanisms of Phenytoin Induced Gingival Overgrowth (2019) · cites this paper as [49]

    The Discussion reports that altered connective-tissue turnover in drug-induced gingival overgrowth results in accumulation of matrix components and fibroplasia. It does not specifically state that the accumulating component is collagen or establish collagen accumulation as the cause of overgrowth. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Reduced AP-1 activates TIMP-1 gene expression.

    “Reduced AP-1 activates the TIMP-1 gene expression.”

    From An Update on the Mechanisms of Phenytoin Induced Gingival Overgrowth (2019) · cites this paper as [49]

    The Discussion (page unavailable) says IL-6 increases TIMP production by fibroblasts, but it does not discuss AP-1 or activation of TIMP-1 gene expression. Searches for reduced AP-1 and for AP-1-mediated TIMP regulation found no passage addressing that mechanism in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 32

  1. [1]Rees TD Levine RA Systemic drugs as a risk factor for periodontal disease initiation and progression Compend Contin Educ Dent 1995 16 20 42 7758039
  2. [2]Thomason JM Kelly PJ Seymour RA The distribution of gingival overgrowth in organ transplant patients J Clin Periodontol 1996 23 367 71 8739169
  3. [3]Tindall OP Friskopp J Drug induced gingival overgrowth – Review Br Dent J 1987 184 305 8
  4. [4]Callard R George AJ Stark J Cytokines, chaos, and complexity Immunity 1999 11 507 13 10591175
  5. [5]Chae HJ Ha MS Yun DH Pae HO Chung HT Chae SW Mechanism of cyclosporine-induced overgrowth in gingiva J Dent Res 2006 85 515 9 16723647
  6. [7]Dongari-Bagtzoglou AI Ebersole JL Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis J Periodontol 1998 69 899 910 9736373
  7. [8]Hong HH Trackman PC Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin J Periodontol 2002 73 145 52 11895278
  8. [9]Kishimoto T The biology of interleukin-6 Blood 1989 74 1 10 2473791
  9. [10]Narayanan AS Meyers DF Page RC Regulation of collagen production in fibroblasts cultured from normal and phenytoin-induced hyperplastic human gingiva J Periodontal Res 1988 23 118 21 2967363
  10. [11]Trackman PC Kantarci A Connective tissue metabolism and gingival overgrowth Crit Rev Oral Biol Med 2004 15 165 75 15187034
  11. [12]Bartold PM Haynes DR Interleukin-6 production by human gingival fibroblasts J Periodontal Res 1991 26 339 45 1831501
  12. [13]Silver RM Interstitial lung disease of systemic sclerosis Int Rev Immunol 1995 12 281 91 7650424
  13. [14]Lonnemann G Engler-Blum G Müller GA Koch KM Dinarello CA Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts Kidney Int 1995 47 845 54 7752583
  14. [15]Feghali CA Bost KL Boulware DW Levy LS Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma J Rheumatol 1992 19 1207 11 1404155
  15. [16]Iacopino AM Doxey D Cutler CW Nares S Stoever K Fojt J Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia J Periodontol 1997 68 73 83 9029455
  16. [17]James JA Linden GJ Drug-induced gingival overgrowth and class II major histo compatibility antigens Transplantation 1998 57 1811 3 8016888
  17. [18]Dongari-Bagtzoglou A Lang N McDoneel HT Drug induced gingival overgrowth Oral Surg Oral Med Oral Pathol 1993 76 543 8 8233439
  18. [19]Morton RS Dongari-Bagtzoglou AI Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A J Periodontol 1999 70 1464 71 10632522
  19. [20]Ellis JS Seymour RA Taylor JJ Thomason JM Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus J Clin Periodontol 2004 31 2 126 31 15016038
  20. [21]Thomason JM Seymour RA Rice N The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth J Clin Periodontol 1993 20 37 40 8421114
  21. [22]Bartold PM Cyclosporine and gingival overgrowth J Oral Pathol 1987 16 463 8 3123625
  22. [23]Hassell TM Hefti AF Drug-induced gingival overgrowth: Old problem, new problem Crit Rev Oral Biol Med 1991 2 103 37 1912141
  23. [24]Myrillas TT Linden GJ Marley JJ Irwin CR Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingiva: Implications for gingival overgrowth J Periodontol 1999 70 294 300 10225546
  24. [25]Williamson MS Miller EK Plemons J Rees T Iacopino AM Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth J Periodontol 1994 65 895 903 7823269
  25. [26]Hirano T Interleukin 6 and its receptor: Ten years later Int Rev Immunol 1998 16 249 84 9505191
  26. [27]Kishimoto T Taga T Akira S Cytokine signal transduction Cell 1994 76 253 62 8293462
  27. [28]Kent LW Rahemtulla F Hockett RD Jr Gilleland RC Michalek SM Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts Infect Immun 1998 66 608 14 9453616 PMC107947
  28. [29]Tüter G Serdar MA Yalim M Gürhan IS Balos K Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients J Periodontol 2002 73 1273 8 12479630
  29. [30]Yamada H Nishimura F Naruishi K Chou HH Takashiba S Albright GM Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts J Periodontol 2000 71 955 60 10914799
  30. [31]Modéer T Domeij H Andurén I Mustafa M Brunius G Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts J Oral Pathol Med 2000 29 491 9 11048965
  31. [32]Romanos GE Schröter-Kermani C Hinz N Herrmann D Strub JR Bernimoulin JP Extracellular matrix analysis of nifedipine-induced gingival overgrowth: Immunohistochemical distribution of different collagen types as well as the glycoprotein fibronectin J Periodontal Res 1993 28 10 6 8426277
  32. [33]Sato T Ito A Mori Y Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts Biochem Biophys Res Commun 1990 170 824 9 2166509

Cited by

Sorted by citations

Authors
Ganesh, P.
Affiliations
Tamil Nadu Government Dental College and Hospital (IN)
Corresponding author
Ganesh, PR
Venue
Contemporary Clinical Dentistry
Published
2016
Volume
7
Issue
2
Pages
140
ISSN
  • 0976-2361 (ISSN-L)
  • 0976-237X
OpenAlex
W2404361092
Cited by
9
References
0
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2021: 2 · 2020: 1 · 2019: 1
FWCI
0.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Contemporary Clinical Dentistry (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Health Professions › Pharmacy › Oral and gingival health research
  • Health Sciences › Dentistry › Periodontics › Oral Health Pathology and Treatment
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
drug-induced gingival hyperplasia, interleukin-6, inflammatory cytokines, phenytoin, cyclosporine, nifedipine, immunohistochemistry, gingival biopsy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review